MR imaging for the noninvasive assessment of atherothrombotic plaques

Magnetic Resonance Imaging Clinics of North America

Volumn 11, Issue 1, 2003, Pages 101-113

  Fayad, Zahi A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CONTRAST MEDIUM;

AORTA ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FUNCTIONAL ANATOMY; IMAGE ANALYSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MONITORING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SWINE; THREE DIMENSIONAL IMAGING; THROMBUS;

EID: 0037304022     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1064-9689(02)00023-5     Document Type: Review

References (99)

1. Farinas PL. A new technique for the arteriographic examination of the abdominal aorta and its branches. AJR Am J Roentgenol 1941;46:641-5.
2. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group [see comments]. N Engl J Med 1995;333:1301-7.
3. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998;279:1615-22.
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
5. Fuster V, Badimon L, Badimon JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326(pt. 1 and 2):242-50 and 310-18.
6. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001;104:365-72.
7. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.
8. Fuster V, Fayad ZA, Badimon JJ. Acute coronary syndromes: biology. Lancet 1999;353(Suppl 2):SII5-9.
9. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657-71.
10. Fuster V. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994;90:2126-46.
11. Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-75.
12. Edelman RR, Chien D, Kim D. Fast selective black blood MRI. Radiology 1991;181:655-60.
13. Simonetti OP, Finn JP, White RD, et al. "Black blood" T2-weighted inversion-recovery MRI of the heart. Radiology 1996;199:49-57.
14. Fayad ZA, Fuster V. Characterization of atherosclerotic plaques by magnetic resonance imaging. Ann N Y Acad Sci 2000;902:173-86.
15. Hatsukami TS, Ross R, Polissar NL, et al. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 2000;102:959-64.
16. Fayad ZA, Fuster V. Clinical imaging of the highrisk or vulnerable atherosclerotic plaque. Circ Res 2001;89:305-16.
17. Yuan C, Mitsumori LM, Beach KW, et al. Carotid atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions. Radiology 2001;221:285-99.
18. Choudhury RP, Fuster V, Badimon JJ, et al. Magnetic resonance imaging and characterization of atherosclerotic plaque: emerging applications and molecular imaging. Arterioscler Thromb Vasc Biol, in press.
19. Edzes HT, Samulski ET. Cross relaxation and spin diffusion in the proton NMR or hydrated collagen. Nature 1977;265:521-3.
20. Toussaint JF, Southern JF, Fuster V, et al. T2-weighted contrast for NMR characterization of human atherosclerosis. Arterioscler Thromb Vasc Biol 1995;15:1533-42.
21. Rapp JH, Connor WE, Lin DS, et al. Lipids of human atherosclerotic plaques and xanthomas: clues to the mechanism of plaque progression. J Lipid Res 1983;24:1329-35.
22. Kucharczyk W, Henkelman RM. Visibility of calcium on MR and CT: can MR show calcium that CT cannot? AJNR Am J Neuroradiol 1994;15:1145-8.
23. Bradley WG Jr. MR appearance of hemorrhage in the brain. Radiology 1993;189:15-26.
24. Yamashita Y, Hatanaka Y, Torashima M, et al. Magnetic resonance characteristics of intrapelvic haematomas. Br J Radiol 1995;68:979-85.
25. Murray JG, Manisali M, Flamm SD, et al. Intramural hematoma of the thoracic aorta: MR image findings and their prognostic implications. Radiology 1997;204:349-55.
26. Corti R, Osende JI, Fuster V, et al. Artery dissection and arterial thrombus aging: the role of noninvasive magnetic resonance imaging. Circulation 2001;103:2420-1.
27. Corti R, Osende JI, Fayad ZA, et al. In vivo noninvasive detection and age definition of arterial thrombus by MRI. J Am Coll Cardiol 2002;39:1366-73.
28. Toussaint JF, LaMuraglia GM, Southern JF, et al. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 1996;94:932-8.
29. Yuan C, Beach KW, Smith LH Jr, et al. Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation 1998;98:2666-71.
30. Fayad ZA, Nahar T, Fallon JT, et al. In vivo MR evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with TEE. Circulation 2000;101:2503-9.
31. Coulden RA, Moss H, Graves MJ, et al. High resolution magnetic resonance imaging of atherosclerosis and the response to balloon angioplasty. Heart 2000;83:188-91.
32. Fayad ZA, Fuster V, Fallon JT, et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 2000;102:506-10.
33. Yuan C, Murakami JW, Hayes CE, et al. Phasedarray magnetic resonance imaging of the carotid artery bifurcation: preliminary results in healthy volunteers and a patient with atherosclerotic disease. J Magn Reson Imaging 1995;5:561-5.
34. Yuan C, Mitsumori LM, Ferguson MS, et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 2001;104:2051-6.
35. Corti R, Fayad ZA, Fuster V, et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 2001;104:249-52.
36. Yuan C, Zhang SX, Polissar NL, et al. Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation 2002;105: 181-5.
37. Summers RM, Andrasko-Bourgeois J, Feuerstein IM, et al. Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia. Circulation 1998;98:509-18.
38. Jaffer FA, O'Donnell CJ, Kissinger KV, et al. MRI assessment of aortic atherosclerosis in an asymptomatic population: The Framingham Heart Study. Circulation 2000;102:II-458.
39. O'Donnell CJ, Larson MG, Jaffer FA, et al. Aortic atherosclerosis detected by MRI is associated with contemporaneous and longitudinal risk factors: The Framingham Heart Study (FHS). Circulation 2000;102:II-836.
40. Worthley SG, Helft G, Fuster V, et al. High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model. Atherosclerosis 2000;150:321-9.
41. Worthley SG, Helft G, Fuster V, et al. Noninvasive in vivo magnetic resonance imaging of experimental coronary artery lesions in a porcine model. Circulation 2000;101:2956-61.
42. Botnar RM, Stuber M, Kissinger KV, et al. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation 2000;102:2582-7.
43. Botnar RM, Kim WY, Bornert P, et al. 3D coronary vessel wall imaging utilizing a local inversion technique with spiral image acquisition. Magn Reson Med 2001;46:848-54.
44. Coombs BD, Rapp JH, Ursell PC, et al. Structure of plaque at carotid bifurcation: high-resolution MRI with histological correlation. Stroke 2001;32:2516-21.
45. Regenfus M, Ropers D, Achenbach S, et al. Noninvasive detection of coronary artery stenosis using contrast-enhanced three-dimensional breathhold magnetic resonance coronary angiography. J Am Coll Cardiol 2000;36:44-50.
46. de Boer OJ, van der Wal AC, Teeling P, et al. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? Cardiovasc Res 1999;41:443-9.
47. McCarthy MJ, Loftus IM, Thompson MM, et al. Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J Vasc Surg 1999;30:261-8.
48. Zhang Y, Cliff WJ, Schoefl GI, et al. Immunohistochemical study of intimal microvessels in coronary atherosclerosis. Am J Pathol 1993;143:164-72.
49. Ware JA. Too many vessels? Not enough? The wrong kind? The VEGF debate continues. Nat Med 2001;7:403-4.
50. Aoki S, Aoki K, Ohsawa S, et al. Dynamic MRI of the carotid wall. J Magn Reson Imaging 1999;9:420-7.
51. Aoki S, Shirouzu I, Sasaki Y, et al. Enhancement of the intracranial arterial wall at MRI: relationship to cerebral atherosclerosis. Radiology 1995;194: 477-81.
52. Yuan C, Kerwin WS, Ferguson MS, et al. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 2002;15:62-7.
53. Lauffer RB, Parmelee DJ, Dunham SU, et al. MS-325: albumin-targeted contrast agent for MR angiography. Radiology 1998;207:529-38.
54. Lin W, Abendschein DR, Haacke EM. Contrast-enhanced magnetic resonance angiography of carotid arterial wall in pigs. J Magn Reson Imaging 1997;7:183-90.
55. Maki JH, Wilson G, Lauffer R, et al. Apparent vessel wall inflammation detected using MS-325, a blood pool contrast agent. Proc Int Soc Mag Reson Med 2001;9:639.
56. Weiss CR, Arai AE, Bui MN, et al. Arterial wall MRI characteristics are associated with elevated serum markers of inflammation in humans. J Magn Reson Imaging 2001;14:698-704.
57. Moreno PR, Falk E, Palacios IF, et al. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 1994;90:775-8.
58. Schmitz SA, Coupland SE, Gust R, et al. Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. Invest Radiol 2000;35:460-71.
59. Ruehm SG, Corot C, Vogt P, et al. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001;103: 415-22.
60. Schmitz SA, Taupitz M, Wagner S, et al. Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles. J Magn Reson Imaging 2001;14:355-61.
61. Burke AP, Farb A, Kolodgie FD, et al. Atherosclerotic plaque morphology and coronary thrombi. J Nucl Cardiol 2002;9:95-103.
62. Johnstone MT, Botnar RM, Perez AS, et al. In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model. Arterioscler Thromb Vasc Biol 2001;21:1556-60.
63. Toussaint JF, Southern JF, Fuster V, et al. Water diffusion properties of human atherosclerosis and thrombosis measured by pulse field gradient nuclear magnetic resonance. Arterioscler Thromb Vasc Biol 1997;17:542-6.
64. Moody AR. Direct imaging of deep-vein thrombosis with magnetic resonance imaging. Lancet 1997;350:1073.
65. Fraser DG, Moody AR, Morgan PS, et al. Diagnosis of lower-limb deep venous thrombosis: a prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med 2002;136:89-98.
66. Moody AR, Liddicoat A, Krarup K. Magnetic resonance pulmonary angiography and direct imaging of embolus for the detection of pulmonary emboli. Invest Radiol 1997;32:431-40.
67. Moody AR, Allder S, Lennox G, et al. Direct magnetic resonance imaging of carotid artery thrombus in acute stroke. Lancet 1999;353:122-3.
68. Mugler JP III, Brookeman JR. Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MP RAGE). Magn Reson Med 1990;15: 152-7.
69. Lanza GM, Lorenz CH, Fischer SE, et al. Enhanced detection of thrombi with a novel fibrin-targeted magnetic resonance imaging agent. Acad Radiol 1998;5(Suppl 1):S173-6.
70. Yu X, Song SK, Chen J, et al. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med 2000;44:867-72.
71. Flacke S, Fischer S, Scott MJ, et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 2001;104:1280-5.
72. Lauffer RB, Graham PB, Lahti KM, et al. Direct clot detection with MRI using a novel fibrin-targeted gadolinium agent. Circulation 2000;102:II-375.
73. Johansson LO, Bjornerud A, Ahlstrom HK, et al. A targeted contrast agent for magnetic resonance imaging of thrombus: implications of spatial resolution. J Magn Reson Imaging 2001;13:615-8.
74. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001;219:316-33.
75. Weissleder R, Moore A, Mahmood U, et al. In vivo magnetic resonance imaging of transgene expression. Nat Med 2000;6:351-5.
76. Louie AY, Huber MM, Ahrens ET, et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 2000;18:321-5.
77. Galis ZS, Muszynski M, Sukhova GK, et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 1994;75:181-9.
78. Davies MJ, Gordon JL, Gearing AJ, et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993;171:223-9.
79. Wood KM, Cadogan MD, Ramshaw AL, et al. The distribution of adhesion molecules in human atherosclerosis. Histopathology 1993;22:437-44.
80. Nakashima Y, Raines EW, Plump AS, et al. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 1998;18:842-51.
81. Sipkins DA, Gijbels K, Tropper FD, et al. ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging. J Neuroimmunol 2000;104:1-9.
82. Anderson SA, Rader RK, Westlin WF, et al. Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles. Magn Reson Med 2000;44:433-9.
83. Nunn AD, Linder KE, Tweedle MF. Can receptors be imaged with MRI agents? Q J Nucl Med 1997;41:155-62.
84. Skinner MP, Yuan C, Mitsumori L, et al. Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med 1995;1:69-73.
85. Trouard TP, Altbach MI, Hunter GC, et al. MRI and NMR spectroscopy of the lipids of atherosclerotic plaque in rabbits and humans. Magn Reson Med 1997;38:19-26.
86. Fayad ZA, Fallon JT, Shinnar M, et al. Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation 1998;98:1541-7.
87. McConnell MV, Aikawa M, Maier SE, et al. MRI of rabbit atherosclerosis in response to dietary cholesterol lowering. Arterioscler Thromb Vasc Biol 1999;19:1956-9.
88. Worthley SG, Helft G, Fuster V, et al. Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis. Circulation 2000;101:586-9.
89. Helft G, Worthley SG, Fuster V, et al. Atherosclerotic aortic component quantification by noninvasive magnetic resonance: an in vivo study in rabbits. J Am Coll Cardiol 2001;37:1149-54.
90. Choudhury RP, Aguinaldo JG, Rong JX, et al. Atherosclerotic lesions in genetically modified mice quantified in vivo by non-invasive high-resolution magnetic resonance microscopy. Atherosclerosis 2002;162:315-21.
91. Helft G, Worthley SG, Fuster V, et al. Progression and regression of atherosclerotic lesions: monitoring with serial noninvasive magnetic resonance imaging. Circulation 2002;105:993-8.
92. Worthley SG, Helft G, Osende JI, et al. Serial evaluation of atherosclerosis with in vivo MRI: study of atorvastatin and avasimibe in WHHL rabbits. Circulation 2000;102:II-809.
93. Zhao XQ, Yuan C, Hatsukami TS, et al. Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study. Arterioscler Thromb Vasc Biol 2001;21:1623-9.
94. Kang X, Polissar NL, Han C, et al. Analysis of the measurement precision of arterial lumen and wall areas using high-resolution MRI. Magn Reson Med 2000;44:968-72.
95. Chan SK, Jaffer FA, Botnar RM, et al. Scan reproducibility of magnetic resonance imaging assessment of aortic atherosclerosis burden. J Cardiovasc Magn Reson 2001;3:331-8.
96. Yuan C, Lin E, Millard J, et al. Closed contour edge detection of blood vessel lumen and outer wall boundaries in black-blood MR images. Magn Reson Imaging 1999;17:257-66.
97. Ladak HM, Thomas JB, Mitchell JR, et al. A semiautomatic technique for measurement of arterial wall from black blood MRI. Med Phys 2001;28: 1098-107.
98. Steinman DA, Thomas JB, Ladak HM, et al. Reconstruction of carotid bifurcation hemodynamics and wall thickness using computational fluid dynamics and MRI. Magn Reson Med 2002;47: 149-59.
99. Song HK, Wright AC, Wolf RL, et al. Multislice double inversion pulse sequence for efficient black-blood MRI. Magn Reson Med 2002;47:616-20.